SCHEMBL7611022

SCHEMBL7611022

C=CC(O[C]=O)C(=O)OC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9543842 0.79 SMN1; SMN2 (0.33)
SCHEMBL7590532 0.76 TSHR (0.33)
SCHEMBL5428033 0.76 TSHR (0.33)
SCHEMBL3868791 0.75
SCHEMBL9718037 0.73 HPGD (0.35)
SCHEMBL3883972 0.72 CA12 (0.33)
SCHEMBL7178426 0.71
SCHEMBL9382388 0.71
SCHEMBL6859303 0.70 SMN1; SMN2 (0.30)
SCHEMBL15697330 0.70 LMNA (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020173468-A1 MODIFIED CYTOSTATIC AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2002-11-21 US disclosed
EP-0240366-B1 Perhydrothiazepine and perhydroazepine derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1994-01-26 EP disclosed
EP-0240366-A2 Perhydrothiazepine and perhydroazepine derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1987-10-07 EP disclosed